Sign in

CIK 0001701108

  • Non-accelerated filer
  • Smaller reporting company

Spero Therapeutics, Inc.

Sign in to watch
Ticker
SPRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-242-1600
Business address
675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
Former names
Spero Therapeutics, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$42,485
in 1 filing

Net −$42,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Rajavelu Esther −$42K Reporting owner sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2026-11-09 Rajavelu Esther Sale −40,851 $1.04 $42K 946,000
2026-05-04 Rajavelu Esther Sale −25,240 $2.51 $63K 986,851
2026-02-06 Rajavelu Esther Sale −37,101 $2.36 $88K 1,062,907
2026-02-06 Rajavelu Esther Sale −50,816 $2.36 $120K 1,012,091
2026-02-02 Rajavelu Esther Grant or award +249,000 1,118,450
2026-02-02 Rajavelu Esther Sale −18,442 $2.20 $41K 1,100,008
2026-02-02 Rajavelu Esther Grant or award · Stock Option (Right to Buy) +498,000 498,000
2025-11-07 Rajavelu Esther Sale −40,270 $2.37 $95K 869,450
2025-05-02 Rajavelu Esther Grant or award +185,000 909,720
2025-02-05 Rajavelu Esther CFO & CBO Sale −20,689 $0.78 $16K 724,720
2025-02-03 Rajavelu Esther CFO & CBO Grant or award +266,139 645,409
2025-02-03 Rajavelu Esther CFO & CBO Grant or award +100,000 745,409
2024-11-08 Rajavelu Esther CFO & CBO Sale −17,245 $1.30 $22K 379,270
2024-11-07 Rajavelu Esther CFO & CBO Sale −23,351 $1.31 $31K 396,515
2024-02-01 Rajavelu Esther Grant or award +119,866 419,866
2023-11-13 Rajavelu Esther Grant or award +300,000 300,000

Page 1 of 1 · 16 trades